DOCSLIB.ORG

SCIENTIFIC PROGRAM Table of Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SCIENTIFIC PROGRAM Table of Contents SCIENTIFIC PROGRAM Table of Contents Welcome Message .................................................................................... 003 Organizing Committee ............................................................................... 006 General Information ................................................................................... 007 Registration ................................................................................................ 008 Transportation ............................................................................................ 009 Floor Plan ................................................................................................... 010 Program at a Glance .................................................................................. 014 SERDF & Prof. Lu Memorial Lectureship ................................................... 017 International Society of Dermatology (ISD) / Taiwan Dermatological Association (TDA).................................................. 020 ISD/TDA Speakers ................................................................................. 035 ISD/TDA Abstracts .................................................................................... 057 Medical Mycology Training Network (MMTN) ............................................ 098 MMTN Speakers ........................................................................................ 101 MMTN Abstracts .................................................................................. 105 Taiwan Dermatopathology Conference (TDPC). ....................................... 112 TDPC Speakers ......................................................................................... 116 TDPC Abstracts .......................................................................................... 121 Free Papers ............................................................................................... 125 Case Reports ............................................................................................. 132 E-posters .................................................................................................... 138 Sponsors .................................................................................................... 147 2 Welcome Message Dear colleagues, It is with great pleasure that we assemble in Taipei for this important and prestigious meeting. The International Society of Dermatology (ISD) is proud to participate in the 6th Continent Congress of Dermatology 2018 and to share this honor with our colleagues from the Taiwanese Dermatological Association. This is our first meeting together and it is with great anticipation that we attend. Many of the Society’s executive board will be here and together wish to thank the organizing committee and especially Dr. Ji-Chen Ho, Honorary Congress President, Dr. Wen-Hung Chung, Honorary Congress President and Dr. Jason, CH Yang, Congress Chair for their hard work and dedication. The ISD is supporting this Congress through scholarships, travel grants and speakers which contribute to its international exposure. For me, this is also a prized opportunity to see and meet colleagues and make new friends while enjoying the culture, hospitality and history of this extraordinary country. These experiences and contacts are at the heart of a meeting’s success and an opportunity for new and seasoned dermatologists to network and learn. I also wish to welcome our new members to the Society The ISD is already represented by members from Taiwan and is stronger because of their contributions. This meeting will be a lasting bridge between your country and global dermatology. This Congress will communicate some of dermatology’s cutting edge ideas while highlighting Taiwan’s role in international medicine. We are grateful for this opportunity to come to Taipei and learn from our colleagues, each of us leaving richer for the experience. Let us enjoy these next few days of learning and international fellowship. Sincerely, George Reizner, MD President, International Society of Dermatology 3 Dear Colleagues and Friends, On behalf of the organizing committee of the Taiwan Dermatological Association (TDA), we are pleased to welcome you to the 6th Continental Congress of Dermatology (CCD), incorporating the 44th Annual Meeting of Taiwanese Dermatological Association (TDA), that will be held at the Taipei International Conference Center (TICC) in Taipei, Taiwan from November 16-18th, 2018. Over the last 10 years, the TDA annual meeting has become synonymous with WKHKLJKHVWFDOLEHUVFLHQWL¿FPHHWLQJLQ'HUPDWRORJ\DFURVV$VLD,WLVRXUKRQRU to host the 6th CCD with the International Society of Dermatology (ISD). The highlights of this year are Nail, Dermoscope, Skin Surgery, Drug Immunology and Fungal Infection. With an overriding theme of “Expanding Horizons,” this conference will provide an extensive program, including plenary VHVVLRQVLQYLWHGOHFWXUHVLQWHUDFWLYHVHVVLRQVDQGZRUNVKRSV7KHVFLHQWL¿F program will cover the spectrum of dermatology, dermatology surgery, and aesthetic subspecialties. Renowned international and regional experts will be sharing their latest discoveries, practice pearls, and up-to-date lectures. Given that Taipei is a distinctly cosmopolitan city with a truly welcoming people, coupled with superior conference venues, we expect the 6th CCD, held in conjunction with the 44th TDA Annual meeting 2018 to be a resounding success. The congress venue is the Taiwan International Conference Center (TICC), a world-class conference center situated in the heart of Taipei, Taiwan’s most vibrant and stylish city, right next to the famous Taipei 101. Last but not least, we would like to thank the International Society of Dermatology (ISD), as well as the organizing committee, scientific committee, speakers, participants, and sponsors for making the meeting a resounding success. We wish you a pleasant and memorable stay here in Taipei, and a fruitful time at the conference. Get ready to inspire and be inspired. Yours sincerely, Honorary Congress President, Ji-Chen Ho Honorary Congress President, Wen-Hung Chung Congress Chair, Jason, CH Yang Ji-Chen Ho Wen-Hung Chung Honorary Congress President Honorary Congress President Jason, CH Yang Yao-Yu Chang Congress Chair Congress Secretary 4 ⏫ἴ䚕冁䦸⏳Ẩ⎱凮㛪憒⸒Ɲ 嬠Ị塏凡䁊䚕冁䦸憒⭟㛪䰳₀⦻Ⓢ㛪媇㑖㭈徵⏫ἴ⎪⊇凡䁊䚕冁䦸憒⭟㛪 䬓 44 Ⱝ⹛㛪Ə⏳㘩凮䬓⅔Ⱝ Continental Congress of Dermatology ᷧ⏳Ḣ徍Ə 㜓㬈⤎㛪⯮㛪凰徍㖣 2018 ⹛ 11 㛯 16 凚 18 㗌✏⏗⋾⛲暂㛪字Ḕ⾪˛✏怵⎢ ⌨⹛敺Ə凡䁊䚕冁䦸憒⭟㛪ᷧ⹛ᷧ⺍䙫⹛㛪℣䄝ⷙㇷ䂡✏㩒巏㕛ῲẅ㴙✗ ⌧檿㰛㹽䙫䚕冁䦸⭟⤎㛪˛ὃ䂡ẅ㴙✗⌧楽Ⱜᷧ㋮䙫⛲暂❲㛪字ƏㇸῸ䛟䕝 㦕⹟僤⤇䈔⎽∗凮 International Society of Dermatology (ISD) ᷧ⏳Ḣ徍䬓⅔Ⱝ CCD˛ 㜓Ⱝ㛪字䙫Ḣ栳㶜咲 Nail˚Dermoscope˚Dermatopathology˚Skin Surgery˚ Drug Immunology ⑳ Fungal InfectionƏ岒䩦Ḣ栳䙫Ḕ⾪〄ペ䂡˥㓛ⰼ好憵Ə ⰼ㜂㜑Ὥ˦˛ㇸῸ奶≪ṭᷧῲ䛟䕝⻊斱䙫字䧲䮫䕮Ə⋬㋓Ḣ栳㻻嬂˚恧媲㻻嬂Ə 恫㛰ṹ⊼『䙫媙䧲⎱ⷌὃ✱ƞ媙䧲ⅎ⮠∮⋬㋓ṭ䚕冁⭟˚䚕冁䛟旃㈲堺⑳憒⭟併 ⮠䛟旃⯯㥔˛䟌⏴䙫⯯⮝Ọ⎱⯯敧柿⟆䙫⭟俬⯮㛪⇭Ẓ㛧㖗䙫䟻䩝䙣䏥˚㛧徸㜆 䙫㜆⇱㕮䍢Ọ⎱悊ẂẽῸ䙫⯝岛䵺樾˛ ⏗⋾ⷩ孤㛰㛧⎲╫➵ⷩḲ䨘Əⅴ⊇ᷱ⛲暂ᷧ㴨䙫㛪字Ḕ⾪ƏㇸῸ㜆⽬⛇䂡㛰わ䙫 ⎪凮Ə䬓⅔Ⱝ CCD 凮䬓 44 Ⱝ凡䁊䚕冁憒⭟㛪⹛㛪⯮㛪⛺㻦ㇷ⊆˛怀㬈㛪字 凰徍✗滅⺎吤㖣⏗⋾ⷩⷩḔ⾪䙫⏗⋾⛲暂㛪字Ḕ⾪ƋTICCƌƏ凮⏗䁊㛧檿䙫 ✗㨀⏗⋾ 101 䂡愗Əㄆ⎾⏗⋾䙫㴢⊂凮㘩Ⰱ˛ 㛧⽳Əㄆ嬄 ISD 恫㛰㈧㛰䙫䰳₀⦻Ⓢ˚⭟堺⦻Ⓢ˚嬂⸒˚凮㛪俬⎱峱⊐┭⎪凮⤎㛪˛ 㜆㜂Ὥ⏗⋾⎪㛪䙫わ惤僤⤇䕀ᷲヰ⿒᷻曊⾿䙫䵺㭞Ƅ 䬓 44 Ⱝ凡䁊䚕冁䦸憒⭟㛪⹛㛪 㦕孤㛪敞 Ἴ⮃㉦ 㦕孤㛪敞 揿㕮⭶ Ḣ⸔ 㤱⾾⋂ 㕓ᷱ Ji-Chen Ho Wen-Hung Chung Ἴ⮃㉦ 揿㕮⭶ 㦕孤㛪敞 㦕孤㛪敞 Jason, CH Yang Yao-Yu Chang 㤱⾾⋂ ⼜㛃⭮ ⤎㛪Ḣ⸔ ⤎㛪䦿㛟敞 5 Organizing Committee Organizer: Taiwanese Dermatological Association (TDA) Co-organizer: Dermatology Chang Gung Memorial Hospital, Taiwan Society for Dermatological and Aesthetic Surgery (TSDAS), Taiwanese Society for Investigative Dermatology (TSID), Taiwanese Photomedicine Society, Asia Fungal Working Group (AFWG), Asian Society of Dermatopathology (ASD) Honorary President: Ji-chen Ho ( Ἴ⮃㉦ ), Wen-hung Chung ( 揿㕮⭶ ) Chairman: Chih-hsun Yang ( 㤱⾾⋂ ) Conference Secretary: Yao-yu Chang ( ⼜㛃⭮ ) Academic Research Section: Hassan Galadari, Evangeline B. Handog, Yu-huei Huang ( 溪㮺デ ), Nellie Konnikov, Cheng-che E. Lan ( 喴㔦ⓙ ) , Pei-hsuan Lu ( ␩ὐ䑮 ), Margaret Mann, Pei-lun Sun (⭒⟠‒), Shyam Verma, Yen-jen Wang (䍲䟻ạ), Yu-hung Wu (␚備⻿) Finance Section: Ya-Ching Chang ( ⼜暬厨 ), Hsin-pei Chen ( 晚㬊ὐ ), Hua-en Lee ( 㜵取ぐ ), Jing-Yi Lin ( 㝾权〈 ), Documentation Section: Rosaline Chung-yee Hui ( 娘ộ䑋 ), Chien-yio Lin ( 㝾〉⎯ ), I-hsin Shih ( 㖤ᷧ㖗 ), Ming-Ying Wu ( ␚㗵䨵 ) Logistic Section: Yung-yi Lee ( 㜵⊮㮬 ), Chun-wei Lu ( 䛎ᾱ䐲 ) Activity Section: Pei-han Kao ( 檿䏕又), Charlene Chau-yee Ng ( 溪㘔䑃), Sze-wen Ting (ᷨ〄㕮), Jennifer Wu(␚⏰⦕) Information Section: Chun-bing Chen ( 晚ᾱ岺 ), Hsi Yen ( 栶䒤 ) Conference Secretary: Chia-jung Lin (㝾὚咰), Min-jyun Luo (佬㔶␂), Yu-han Wu (␚曏㶜), Mamie Hao-an Chao (嶀㙎⭰) ⟥㗁᳹塔塸䐩⩴ Conference Artist 䫟ᶉ Brief Introduction 㙕⩕䪂 Tsung Fan Lin 1979 ⹛䔆㖣⏗䁊⏗⋾Ə䕉㥔㖣⾐凯┭ⷌ⻊␱娔姯䦸⎱㨠⾞⤎⭟⮋ⅎ娔姯䳢˛䔘㖣䈝妑䆘㄂併堺ḍ㒬敞㰛⢏ⱘ㰛䕒ὃƏ ⾅⯶Ⱈㇷ敞✏嗄堺䒗⡪Ə⛇㭋ὃ⒨ⅎ㶜⸟ℬ㺉吾㝘㖠㰛⢏䫇㲼⟡⹼Ə㖣ὃ⒨Ḕₚ总⇡┖併䩡敺䙫噂⯍䧐⹶ㄆ˛⯴㖣 ䷁㢄Ə䩡敺⑳剙⠱拑晚Ə䙭桖䏥⇡䛟䕝ㇷ䆆俳䩐⁌䙫㍳㏈ . 䕒ὃḔᷧ㙖ᷧ䉐䙫䴫⏯Əῄ㛰吾ᷧ䈮恣斱䙫权嫷Ə✏䰈㼻 ⛽₶塏⾜Ḕ , Ẵ嗱㶜吾䄈昷⻝἟䙫併⭟⍗屈 . 忶怵≜ὃὭₚ总ẽ忤⯲⹟䥶䙫㞷ᷧ㮜㖬䧲Ə⇄䴷‣⽾ᷧⅴ⛅⑚䙫㘩ℰƏ Ọ⎱⯴惰✆䙫䆘㄂ . ὃ⒨Ḕ㴨朙⇡ᷧ䨕䲥䄰䙫乑⛽㈲㲼Ə⯮䑗湾䙫䳬˚喴˚䴒˚䶇䬰剙媦廼㞻⋽Ə␯䏥⇡⯎权俳ょ敹 䙫㖬怱⾪⡪˛ Tsung Fan Lin was born in 1979 in Taipei, Taiwan. He studied advertising design at Fu-Hsin Trade and Arts School and majored in interior design at Shu-Te University. Because his father had a passion for the arts and specialized in landscape ink paintings, Lin grew up in an environment that was intimately connected with art. As a result, his works often have a foundation in Oriental ink paintings, and convey an awareness of virtual order in an aesthetic space. Linćs use of lines, spaces, and colors in his paintings highlight his mature and steady mastery, in which he preserves a sense of vast tranquility with his combination of scenes and objects. Linćs image characterization is FRQFLVH\HWHYRNHVWKHDHVWKHWLFLPSUHVVLRQRILQ¿QLWHH[WHQVLRQ7KURXJKKLVZRUN/LQVKDUHVKLVMRXUQH\IRUWKH
Load more

Recommended publications
  • Acral Compound Nevus SJ Yun S Korea
    University of Pennsylvania, Founded by Ben Franklin in 1740 Disclosures Consultant for Myriad Genetics and for SciBase (might try to sell you a book, as well) Multidimensional Pathway Classification of Melanocytic Tumors WHO 4th Edition, 2018 Epidemiologic, Clinical, Histologic and Genomic Aspects of Melanoma David E. Elder, MB ChB, FRCPA University of Pennsylvania, Philadelphia, PA, USA Napa, May, 2018 3rd Edition, 2006 Malignant Melanoma • A malignant tumor of melanocytes • Not all melanomas are the same – variation in: – Epidemiology – risk factors, populations – Cell/Site of origin – Precursors – Clinical morphology – Microscopic morphology – Simulants – Genomic abnormalities Incidence of Melanoma D.M. Parkin et al. CSD/Site-Related Classification • Bastian’s CSD/Site-Related Classification (Taxonomy) of Melanoma – “The guiding principles for distinguishing taxa are genetic alterations that arise early during progression; clinical or histologic features of the primary tumor; characteristics of the host, such as age of onset, ethnicity, and skin type; and the role of environmental factors such as UV radiation.” Bastian 2015 Epithelium associated Site High UV Low UV Glabrous Mucosa Benign Acquired Spitz nevus nevus Atypical Dysplastic Spitz Borderline nevus tumor High Desmopl. Low-CSD Spitzoid Acral Mucosal Malignant CSD melanoma melanoma melanoma melanoma melanoma 105 Point mutations 103 Structural Rearrangements 2018 WHO Classification of Melanoma • Integrates Epidemiologic, Genomic, Clinical and Histopathologic Features • Assists
    [Show full text]
  • Optimal Management of Common Acquired Melanocytic Nevi (Moles): Current Perspectives
    Clinical, Cosmetic and Investigational Dermatology Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Optimal management of common acquired melanocytic nevi (moles): current perspectives Kabir Sardana Abstract: Although common acquired melanocytic nevi are largely benign, they are probably Payal Chakravarty one of the most common indications for cosmetic surgery encountered by dermatologists. With Khushbu Goel recent advances, noninvasive tools can largely determine the potential for malignancy, although they cannot supplant histology. Although surgical shave excision with its myriad modifications Department of Dermatology and STD, Maulana Azad Medical College and has been in vogue for decades, the lack of an adequate histological sample, the largely blind Lok Nayak Hospital, New Delhi, Delhi, nature of the procedure, and the possibility of recurrence are persisting issues. Pigment-specific India lasers were initially used in the Q-switched mode, which was based on the thermal relaxation time of the melanocyte (size 7 µm; 1 µsec), which is not the primary target in melanocytic nevus. The cluster of nevus cells (100 µm) probably lends itself to treatment with a millisecond laser rather than a nanosecond laser. Thus, normal mode pigment-specific lasers and pulsed ablative lasers (CO2/erbium [Er]:yttrium aluminum garnet [YAG]) are more suited to treat acquired melanocytic nevi. The complexities of treating this disorder can be overcome by following a structured approach by using lasers that achieve the appropriate depth to treat the three subtypes of nevi: junctional, compound, and dermal. Thus, junctional nevi respond to Q-switched/normal mode pigment lasers, where for the compound and dermal nevi, pulsed ablative laser (CO2/ Er:YAG) may be needed.
    [Show full text]
  • Seminar ICLAD 2019 Classification of Silicone Foreign Body Reaction.Pdf
    SIMPOSIUM Day/ Date: Friday, 26th 2019 Time Schedule Speaker Time Schedule Speaker 07.30- Registration 08.00 Session I: Moderator: David Session II: Wound Moderator: Larisa Fundamentals of Sudarto Oeiria, Dr. Healing in Paramitha Laser & Other Sp.KK, FINSDV, Dermatologic Wibawa, Dr. Sp.KK, Energy Based FAADV Procedure FINSDV Devices: Update 08.00- Biophysics of Laser David Sudarto 08.00- Basic Wound Theresia L. Toruan, 08.20 and Other Energy Oeiria, Dr. Sp.KK, 08.15 Healing in Reducing Sp.KK(K), Prof. Dr. Based Devices FINSDV, FAADV Scar FINSDV, FAADV 08.20- Skin Conditioning Aryani Sudharmono, 08.15- Silicone Gel Usage in M. Akbar 08.40 Regimen for Laser Dr. Sp.KK(K), 08.30 Invasive Wedyadhana, Dr. and Other Energy FINSDV, FAADV Dermatologic Sp.KK, FINSDV Based Devices Procedure Treatment 08.40- Discussion 08.30- Silicone Gel for Yuli Kurniawati, DR. 08.50 08.45 Keloid and Dr. Sp.KK(K), Hypertrophic Scar FINSDV, FAADV 08.45- Discussion 08.50 Time Schedule Speaker Schedule Speaker Plenary Session I Moderator: Made Swastika Adiguna, Prof. Co moderator: Luh Made Mas Rusyati, DR . Dr. Dr. Sp.KK(K), FINSDV, FAADV Sp.KK(K), FINSDV 08.50- To be confirmed To be confirmed 09.10 09.10- Dermatologic Surgery: The History, Present, Lawrence M. Field, Prof. MD 09.40 and Future 09.40- Lillis Tumescent Anesthesia Patrick J. Lilis, MD 10.10 10.10- Discussion 10.20 10.20- Opening Welcome Speech: 10.30 1. Chairman of ICLAD 2.Chairman of PERDOSKI 10.30- Coffee Break 10.45 Sesi III: Stem Cell Moderator: Session IV: Moderator: Made and Growth Factor: Amaranila Lalita Malignancy Wardhana, DR.
    [Show full text]
  • 8.5 X12.5 Doublelines.P65
    Cambridge University Press 978-0-521-87409-0 - Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions Edited by Markku Miettinen Index More information Index abdominal ependymoma, 744 mucinous cystadenocarcinoma, 631 adult fibrosarcoma (AF), 364–365, 1026 abdominal extrauterine smooth muscle ovarian adenocarcinoma, 72, 79 adult granulosa cell tumor, 523–524 tumors, 79 pancreatic adenocarcinoma, 846 clinical features, 523 abdominal inflammatory myofibroblastic pulmonary adenocarcinoma, 51 genetics, 524 tumors, 297–298 renal adenocarcinoma, 67 pathology, 523–524 abdominal leiomyoma, 467, 477 serous cystadenocarcinoma, 631 adult rhabdomyoma, 548–549 abdominal leiomyosarcoma. See urinary bladder/urogenital tract clinical features, 548 gastrointestinal stromal tumor adenocarcinoma, 72, 401 differential diagnosis, 549 (GIST) uterine adenocarcinomas, 72 genetics, 549 abdominal perivascular epithelioid cell tumors adenofibroma, 523 pathology, 548–549 (PEComas), 542 adenoid cystic carcinoma, 1035 aggressive angiomyxoma (AAM), 514–518 abdominal wall desmoids, 244 adenomatoid tumor, 811–813 clinical features, 514–516 acquired elastotic hemangioma, 598 adenomatous polyposis coli (APC) gene, 143 differential diagnosis, 518 acquired tufted angioma, 590 adenosarcoma (mullerian¨ adenosarcoma), 523 genetics, 518 acral arteriovenous tumor, 583 adipocytic lesions (cytology), 1017–1022 pathology, 516 acral myxoinflammatory fibroblastic sarcoma atypical lipomatous tumor/well- aggressive digital papillary adenocarcinoma, (AMIFS), 365–370, 1026 differentiated
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • Acral Melanoma
    Accepted Date : 07-Jul-2015 Article type : Original Article The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma Running head: Dermoscopy of acral melanoma Word count: 3138, Tables: 6, Figures: 6 A. Lallas,1 A. Kyrgidis,1 H. Koga,2 E. Moscarella,1 P. Tschandl,3 Z. Apalla,4 A. Di Stefani,5 D. Ioannides,2 H. Kittler,4 K. Kobayashi,6,7 E. Lazaridou,2 C. Longo,1 A. Phan,8 T. Saida,3 M. Tanaka,6 L. Thomas,8 I. Zalaudek,9 G. Argenziano.10 Article 1. Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy 2. Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan 3. Department of Dermatology, Division of General Dermatology, Medical University, Vienna, Austria 4. First Department of Dermatology, Medical School, Aristotle University, Thessaloniki, Greece 5. Division of Dermatology, Complesso Integrato Columbus, Rome, Italy 6. Department of Dermatology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan 7. Kobayashi Clinic, Tokyo, Japan 8. Department of Dermatology, Claude Bernard - Lyon 1 University, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. 9. Department of Dermatology and Venereology, Medical University, Graz, Austria 10. Dermatology Unit, Second University of Naples, Naples, Italy. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as Accepted doi: 10.1111/bjd.14045 This article is protected by copyright. All rights reserved. Please address all correspondence to: Aimilios Lallas, MD.
    [Show full text]
  • Acral Lentiginous Melanoma in Situ: Dermoscopic Features and Management Strategy Byeol Han1,2, Keunyoung Hur1, Jungyoon Ohn1,2, Sophie Soyeon Lim3 & Je‑Ho Mun1,2*
    www.nature.com/scientificreports OPEN Acral lentiginous melanoma in situ: dermoscopic features and management strategy Byeol Han1,2, Keunyoung Hur1, Jungyoon Ohn1,2, Sophie Soyeon Lim3 & Je‑Ho Mun1,2* Diagnosis of acral lentiginous melanoma in situ (ALMIS) is challenging. However, data regarding ALMIS are limited in the literature. The aim of this study was to investigate the clinical and dermoscopic features of ALMIS on palmoplantar surfaces. Patients with ALMIS and available dermoscopic images were retrospectively reviewed at our institution between January 2013 and February 2020. Clinical and dermoscopic features were analysed and compared between small (< 15 mm) and large (≥ 15 mm) ALMIS. Twenty‑one patients with ALMIS were included in this study. Mean patient age was 58.5 (range 39–76) years; most lesions were located on the sole (90.5%). The mean maximal diameter was 19.9 ± 13.7 mm (mean ± standard deviation). Statistical analysis of dermoscopic features revealed that parallel ridge patterns (54.5% vs. 100%, P = 0.035), irregular difuse pigmentation (27.3% vs. 100%, P = 0.001) and grey colour (18.2% vs. 90%, P = 0.002) were signifcantly less frequent in small lesions than in large lesions. We have also illustrated two unique cases of small ALMIS; their evolution and follow‑up dermoscopic examination are provided. In conclusion, this study described detailed dermoscopic fndings of ALMIS. Based on the present study and a review of the literature, we proposed a dermoscopic algorithm for the diagnosis of ALMIS. Acral lentiginous melanoma (ALM), frst described by Reed in 1976, is a histological subtype of cutaneous melanoma arising on the acral areas1,2.
    [Show full text]
  • UC Davis Dermatology Online Journal
    UC Davis Dermatology Online Journal Title Morphea-like complications to illicit gluteal silicone injections Permalink https://escholarship.org/uc/item/0xv5g3sn Journal Dermatology Online Journal, 21(4) Authors Tausend, William E Stewart, Larissa R Rapini, Ronald P Publication Date 2015 DOI 10.5070/D3214026271 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 21 Number 4 April 2015 Case presentation Morphea-like complications to illicit gluteal silicone injections William E. Tausend MD1, Larissa R. Stewart MD2, Ronald P. Rapini MD2 Dermatology Online Journal 21 (4): 5 1University of Texas Medical Branch Department of Dermatology 2University of Texas Health Science Center-Houston Department of Dermatology Correspondence: William E. Tausend, MD 1122 Postoffice St. Galveston, Texas 77550 Phone-832-816-5524 [email protected] Abstract We present a case of a 39-year-old Hispanic woman who was referred to our clinic for treatment of several indurated plaques on her buttocks that developed one year prior to presentation, after she received injections of an unknown substance for augmentation. Biopsy of one nodule revealed silicone in the dermis. Keywords: Silicone injection, Procedural complications Introduction Illicit injections of silicone are an increasing and worrisome trend in the United States, especially in the Hispanic and transgender communities [1]. These procedures are often performed by unlicensed individuals who inject large quantities of unknown substances into patients [2,3]. The reasons for this increasing trend are thought to relate to the reduced cost of the procedures [4,5].
    [Show full text]
  • Misdiagnosed, Mistreated and Delay
    erimenta xp l D E e r & m l a a t c o i l n o i Journal of Clinical & Experimental Scalvenzi et al., J Clin Exp Dermatol Res 2012, S:6 l g y C f R DOI: 10.4172/2155-9554.S6-002 o e l ISSN: 2155-9554 s a e n a r r u c o h J Dermatology Research Research Article Open Access Misdiagnosed, Mistreated and Delay Diagnosed Acral Melanoma: The Atypical Presentations Scalvenzi M*, Palmisano F and Costa C Departments of Dermatology, University of Naples Federico II, Italy Abstract Background: Acral skin is the most common site of malignant melanoma in non-Caucasian population. Diagnosis in this anatomic site is often delayed because this area is not routinely examined by patients or primary physicians. Objective: To perform an earlier diagnosis underlining the importance of dermoscopy helping clinicians to differentiate this disease from the other lesions and biopsies will result in more timely diagnoses and improved survival. Methods: We present 6 case studies visited in our Department of Dermatology of Naples University between October 2010 and September 2012. Results: These lesions often mimic other entities like warts, calli, bacterial or fungal infections, foreign bodies, vascular lesions, blisters, melanocytic nevi, subungual hematomas, pyogenic granulomas, onychomycosis, keratoacanthomas, diabetic foot ulcers, traumatic lesions that can lead to misdiagnosis and mistreatment. Conclusions: Awareness of atypical presentations of acral melanoma may be important to decrease misdiagnosis rates and improve patient outcome. Keywords: Acral melanoma; Foot; Misdiagnosis; Dermoscopy 5 cm in diameter (Figure 3a), misdiagnosed as a wart and treated for seven months with cryotherapy.
    [Show full text]
  • Qt5085f0pn.Pdf
    UC San Diego UC San Diego Previously Published Works Title Foreign Body Granulomas after All Injectable Dermal Fillers: Part 2. Treatment Options Permalink https://escholarship.org/uc/item/5085f0pn Author Lemperle, Gottfried Publication Date 2015-04-05 Peer reviewed eScholarship.org Powered by the California Digital Library University of California SPECIAL TOPIC Foreign Body Granulomas after All Injectable Dermal Fillers: Part 2. Treatment Options Foot Gottfried Lemperle, M.D., Summary: Foreign body granulomas occur at certain rates with all injectable Ph.D. dermal fillers. They have to be distinguished from early implant nodules, which Nelly Gauthier-Hazan, M.D. usually appear 2 to 4 weeks after injection. In general, foreign body granulomas San Diego, Calif.; and Paris, France appear after a latent period of several months at all injected sites at the same time. If diagnosed early and treated correctly, they can be diminished within a few weeks. The treatment of choice of this hyperactive granulation tissue is the intralesional injection of corticosteroid crystals (triamcinolone, betamethasone, or prednisolone), which may be repeated in 4-week cycles until the right dose is found. To lower the risk of skin atrophy, corticosteroids can be combined with antimitotic drugs such as 5-fluorouracil and pulsed lasers. Because foreign body granulomas grow fingerlike into the surrounding tissue, surgical excision should be the last option. Surgery or drainage is indicated to treat normal lumps and cystic foreign body granulomas with little tissue ingrowth. In most patients, a foreign body granuloma is a single event during a lifetime, often triggered by a systemic bacterial infection. (Plast.
    [Show full text]
  • “Highly Cohesive” Silicone Breast Implants: a Histopathologic and Laser Raman Microprobe Analysis
    International Journal of Environmental Research and Public Health Article A Case of Silicone and Sarcoid Granulomas in a Patient with “Highly Cohesive” Silicone Breast Implants: A Histopathologic and Laser Raman Microprobe Analysis Todor I. Todorov 1,†, Erik de Bakker 2,3, Diane Smith 4,‡, Lisette C. Langenberg 5, Linda A. Murakata 1,§, Mark H. H. Kramer 6 , Jose A. Centeno 1,k and Prabath W. B. Nanayakkara 4,* 1 Department of Environmental and Infectious Disease Sciences, Division of Biophysical Toxicology, Armed Forces Institute of Pathology, Washington, DC 20306, USA; [email protected] (T.I.T.); [email protected] (L.A.M.); [email protected] (J.A.C.) 2 Department of Plastic Surgery, VU University Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; [email protected] 3 Department of Molecular Cell Biology and Immunology, VU University Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands 4 Henry Jackson Foundation, Bethesda, MD 20817, USA; [email protected] 5 Department of Internal Medicine, VU University Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; [email protected] 6 Department of Pathology, VU University Medical Centre, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; [email protected] * Correspondence: [email protected] † Current address: Center for Food Safety and Applied Nutrition, US Food and Drug Administration, Citation: Todorov, T.I.; de Bakker, E.; College Park, MD 20740, USA. Smith, D.; Langenberg, L.C.; ‡ Current address: Center for Device and Radiological Health, US Food and Drug Administration, Murakata, L.A.; Kramer, M.H.H.; Silver Spring, MD 20993, USA.
    [Show full text]
  • Dermoscopic Patterns of Acral Melanocytic Lesions in Skin of Color
    SKIN OF COLOR IN COLLABORATION WITH THE SKIN OF COLOR SOCIETY Dermoscopic Patterns of Acral Melanocytic Lesions in Skin of Color Andrea Tan, BS; Jennifer A. Stein, MD, PhD Population Trends in Skin of Color PRACTICE POINTS Much of the literature on malignant melanoma his- • Dermatologists should be familiar with common torically has involved non-Hispanic white patients, but dermoscopic patterns seen at acral sites in patients the incidence in lighter-skinned populations has been with skin of color as well as the most up-to-date increasing steadily over the last few decades.1 Although diagnostic algorithms. ALM can occur in any race, it disproportionately affects • Acral lentiginous melanoma should be strongly sus- skin of color populations;copy ALM accounts for only 0.8% to pected if dermoscopy reveals a parallel ridge pattern 1% of all melanomas in white populations, but it consti- or if dermoscopy of volar skin reveals a lack of typi- tutes 4% to 58% of melanomas in ethnic populations and cal dermoscopic patterns in lesions with a diameter is the most common melanoma subtype among black greater than 7 mm. Americans.2-5 Acral lentiginous melanoma also is associ- atednot with a worse prognosis compared to other subtypes, which may indicate a more aggressive biological nature6 but also may point toward socioeconomic and cultural Acral lentiginous melanoma (ALM) is a rare but aggressive subtype barriers (eg, low income or education levels, lack of insur- of melanoma often associated with poor prognosis. Although overallDo incidence is rare, ALM accounts for a larger proportion of mela- ance, lower health literacy), leading to disparities in access 5 nomas among black, Asian, and Hispanic individuals than among to care and diagnosis at advanced stages.
    [Show full text]